Clinical Trials Resource Center

Ongoing Trials at UTHealth

DERMATOLOGIC (SKIN disorders)

 

Psoriasis Study for Adolescents
A Phase 1, Open-Label, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of Calcipotriene Foam, 0.005%, Applied Under Maximal-Use Conditions in Adolescent Subjects (Ages 12 to 16 Years) with Plaque Psoriasis
Coordinator Name: Rhea Elliott
E-mail: Rhea.e.elliott@uth.tmc.edu
Phone: 713-500-8280
Coordinator Name: Maria Lopez
E-mail: maria.d.lopez@uth.tmc.edu
Phone: 713-500-8266
Principal Investigator: Adelaide A. Hebert, MD
for more information – clinicaltrials.gov

Target Population: Boys and girls ages 12 to 16 years with psoriasis

Psoriasis Study for Children
A Multicenter, Randomized, Double-Blind, Phase 3 Study of the Safety, Efficacy, Systemic Exposure, and Pharmacodynamics of Calcipotriene Foam, 0.005%, Versus Vehicle Foam in Pediatric Subjects (Ages 2 to 11 Years) with Plaque Psoriasis
Coordinator Name: Rhea Elliott
E-mail: Rhea.e.elliott@uth.tmc.edu
Phone: 713-500-8280
Coordinator Name: Maria Lopez
E-mail: maria.d.lopez@uth.tmc.edu
Phone: 713-500-8266
Principal Investigator: Adelaide A. Hebert, MD
for more information - clinicaltrials.gov

Target Population: Boys and girls ages 2 to 11 years with psoriasis

Psoriasis Study for Children
A Multicenter, Randomized, Double Blind, Parallel Group, Vehicle Controlled Study of the Safety and Efficacy of Calcitriol 3 mcg/g Ointment Applied Twice Daily for 8 Weeks in Pediatric Subjects (2 to 12 Years of Age) with Mild to Moderate Plaque Psoriasis
Coordinator Name: Rhea Elliott
E-mail: Rhea.e.elliott@uth.tmc.edu
Phone: 713-500-8280
Coordinator Name: Maria Lopez
E-mail: maria.d.lopez@uth.tmc.edu
Phone: 713-500-8266
Principal Investigator: Adelaide A. Hebert, MD
for more information - clinicaltrials.gov

Target Population: Boys and girls ages 2 to 12 years with psoriasis

Atopic Dermatitis Study for Children
A Multi-Center, Open Label, Phase 1 Study to Evaluate the Safety of Both MSRD-100 (Fluticasone Propionate) Gel 0.025% and Fluticasone Propionate Cream 0.05% Including its Effects on the Hypothalamic Pituitary Adrenal (HPA) Axis in the Treatment of Atopic Dermatitis in Pediatric Subjects
Coordinator Name: Rhea Elliott
E-mail: Rhea.e.elliott@uth.tmc.edu
Phone: 713-500-8280
Coordinator Name: Maria Lopez
E-mail: maria.d.lopez@uth.tmc.edu
Phone: 713-500-8266
Principal Investigator: Adelaide A. Hebert, MD

Target Population: Boys and girls ages 3 months to 6 years

GASTROINTESTINAL / HEPATIC

 

HEALTHY VOLUNTEERS

 

Individual differences in the motivational value of reward cues “Responses to Food and Pictures” (Snack Study)
Coordinator: Paula Lopez-Gamundi
E-mail: Paula.LopezGamundi@uth.tmc.edu
Phone: 713-486-2578
Principal Investigator: Margaret Wardle, PhD

HEART & VASCULAR

ALLSTAR
Coordinator Name: Deborah Barr
E-mail: deborah.d.barr@uth.tmc.edu
Phone: 713-500-6598
Principal Investigator: H.V. Anderson, MD
for more information – clinicaltrials.gov

Study Overview: The ALLSTAR Study will evaluate the Safety and Efficacy of Intracoronary Delivery of Allogeneic Cardiosphere-Derived Cells (Stem Cells) in Patients With an Anterior Heart Attack and Ischemic Left Ventricular Dysfunction.

Target Population: Patients with previous heart attack (within 1 month – 12 months of study treatment)

 

Century Health
Coordinator Name: Catey Carter, RN 
E-mail: catharine.v.carter@uth.tmc.edu 
Phone: 713-500-5200 
E-mail: ms.century@uth.tmc.edu 
Phone: 713-500-5200 
Principal Investigator: K. Lance Gould, MD
for more information - clinicaltrials.gov
or  http://www.uth.tmc.edu/pet/century-study/

COAPT Trial
Coordinator Name: Rhonda Patterson
E-mail: rhonda.s.patterson@uth.tmc.edu
Phone: 713-500-6550
Principal Investigator: Richard Smalling. MD
for more information – clinicaltrials.gov

Study Overview: The purpose of the Clinical Outcomes Assessment of the MitraClip Percutaneous Therapy for High Surgical Risk Patients (COAPT) Trial is to confirm the safety and effectiveness of the MitraClip System for the treatment of moderate-to-severe or severe functional mitral regurgitation (FMR) in high surgical risk subjects.

Target Population: Patients with Mitral Valve Regurgitation

 

PARTNER II Trial
Coordinator Name: Susan Davidson
E-mail: susan.l.davidson@uth.tmc.edu
Phone: 713-500-5219
Coordinator Name: Belinda Metts
E-mail: belinda.j.metts@uth.tmc.edu
Phone: 713-500-5219
Principal Investigator: Richard Smalling, MD
for more information – clinicaltrials.gov

Study Overview: The purpose of this research study is to study the safety and effectiveness of the Edwards SAPIEN XT™ Transcatheter Heart Valve (THV) and associated delivery systems (transfemoral, transapical and transaortic), which are intended for use in patients with symptomatic, calcific, severe aortic stenosis.

Target Population: Patients with severe aortic stenosis

The SECRET of CHF
Coordinator Name: Deborah Barr
E-mail: deborah.d.barr@uth.tmc.edu 
Phone: 713-500-6598
Principal Investigator: Prakash Balan, MD
for more information – clinicaltrials.gov

Study Overview: The SECRET of CHF Study will evaluate the short term efficacy and safety of tolvaptan in subjects hospitalized for worsening heart failure who have volume overload and one of the following: renal insufficiency, or hyponatremia or inadequate response to diuretic therapy.

Target Population: Patients admitted to the hospital with heart failure and volume overload

Sentinel Study
Coordinator Name: Belinda Metts
E-mail: belinda.j.metts@uth.tmc.edu
Phone: 713-500-5219
Principal Investigator: Richard Smalling, MD
for more information – clinicaltrials.gov

Study Overview: The Sentinel Study is a randomized controlled trial that will assess the safety and efficacy of the Claret Medical Sentinel Cerebral Protection System used for embolic protection during Transcatheter Aortic Valve Replacement (TAVR) compared to the TAVR standard of care (without embolic protection).

Target Population: Patients with severe aortic stenosis who are undergoing TAVR

HEMODIALYSIS

Heparin-bonded versus Non-heparin-bonded Polytetrafluroethylene Hemodialysis Access Grafts
Coordinator Name: Samuel Leake
E-mail: Samuel.S.Leake@uth.tmc.edu 
Phone: 713-486-5120
Principal Investigator: Kristofer Charlton-Ouw, MD
for more information - clinicaltrials.gov

HIV

 

HYPERTENSION

Determination of Genetics in Childhood Onset Hypertension 
Coordinator Name: Josephine Turner
Phone: 713-704-4137
Email: Josephine.Turner@uth.tmc.edu
Coordinator Name: Cary Warner
Phone Number: 713-704-3743
Principal Investigator: Monesha Gupta, MD
for more information - PDF flyer

LYMPHATIC

 

Lymph Angiography in Normal and Lymphatic Disorders
Phone: 713-500-3562 
Coordinator Name: David Kleiman 
E-mail: David.M.Kleiman@uth.tmc.edu 
Phone: 713-500-3595 
Principal Investigator: Eva Sevick, PhD

NEUROLOGIC

 

Aseptic Meningoencephalitis in Adults 
Coordinator Name: Monika Ruscheinsky 
E-mail: monika.ruscheinsky@uth.tmc.edu   
Phone: 713-704-0825 
Principal Investigator: Rodrigo Hasbun, MD, MPH

 

ASSIST: Acute Stroke and Spleen Size 
Coordinator Name: Jennifer Garrett, RN
E-mail: Jennifer.M.Garrett@uth.tmc.edu
Phone: 713-500-7183 
Principal Investigator: Sean Savitz, MD

Human Epilepsy Project
Coordinator Name: Kara Kime
E-mail: Kara.L.Kime@uth.tmc.edu
Phone: 713-500-7070
Principal Investigator: Robert Knowlton, MD
for more information - http://humanepilepsyproject.org/

A Prospective, Open-label Study of the Structure and Function of the Retina in Adult Patients with Refractory Complex Partial Seizures Treated with Vigabatrin (Sabril®)
Coordinator Name: Kara Kime
E-mail: Kara.L.Kime@uth.tmc.edu
Phone: 713-500-7070
Principal Investigator: Jeremy Slater, MD
for more information - clinicaltrials.gov

VNS Therapy Automatic Magnet Mode Outcomes Study in Epilepsy Patients Exhibiting Ictal Tachycardia
Coordinator Name: Kara Kime
E-mail: Kara.L.Kime@uth.tmc.edu
Phone: 713-500-7070
Principal Investigator: Jeremy Slater, MD
for more information - clinicaltrials.gov

PSYCHOLOGIC

 

Autism Spectrum Disorders and Symptoms of ADHD 
Coordinator Name: Rosleen Mansour 
E-mail: Rosleen.Mansour@uth.tmc.edu 
Phone: 713-486-2591  
Principal Investigator: Deborah A. Pearson, PhD
for more information - clinicaltrials.gov

A Double-blind Randomized Placebo-controlled Study of Aspirin and N-acetyl Cysteine as Adjunctive Treatments for Bipolar Disorder Patients
Coordinator Name: Danielle Spiker
E-mail: danielle.e.spiker@uth.tmc.edu
Phone: 713-486-2627
Coordinator Name: Lindsay Brewer
E-mail: lindsay.d.harris@uth.tmc.edu
Phone: 713-486-2527
Principal Investigator: Jair C. Soares, MD

Searching for Endophenotypes of Bipolar Disorder
Coordinator Name: Danielle Spiker
E-mail: danielle.e.spiker@uth.tmc.edu
Phone: 713-486-2627
Coordinator Name: Lindsay Brewer
E-mail: lindsay.d.harris@uth.tmc.edu
Phone: 713-486-2527
Principal Investigator: Jair C. Soares, MD

Deep Brain Stimulation (DBS) Therapy for Treatment Resistant Depression
Coordinator Name: Danielle Spiker
E-mail: danielle.e.spiker@uth.tmc.edu
Phone: 713-486-2627
Coordinator Name: Lindsay Brewer
E-mail: lindsay.d.harris@uth.tmc.edu
Phone: 713-486-2527
Principal Investigator: Jair C. Soares, MD

Pediatric Bipolar Registry
Coordinator Name: Danielle Spiker
E-mail: danielle.e.spiker@uth.tmc.edu
Phone: 713-486-2627
Coordinator Name: Lindsay Brewer
E-mail: lindsay.d.harris@uth.tmc.edu
Phone: 713-486-2527
Principal Investigator: Jair C. Soares, MD

PULMONARY

Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program (PAH QuERI Ext)
Coordinator Name: Kristi Morin, RN, BSN
E-mail: Kristi.l.baysinger@uth.tmc.edu 
Phone: 713-500-6851
Principal Investigator: Bela Patel, MD
for more information - clinicaltrials.gov

Trial of the Early Combination of Oral Treprostinil With a PDE-5 Inhibitor or ERA in Subjects With Pulmonary Arterial Hypertension (FREEDOM-Ev)
Coordinator Name: Kristi Morin, RN, BSN
E-mail: Kristi.l.baysinger@uth.tmc.edu 
Phone: 713-500-6851
Principal Investigator: Bela Patel, MD
for more information - clinicaltrials.gov

REPRODUCTIVE

 

SCLERODERMA

Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
Coordinator Name: Ann Saulino, RN
E-mail: Ann.R.Saulino@uth.tmc.edu 
Phone: 713-500-7118
Additional Contact: Kristi Morin, RN, BSN
E-mail: Kristi.l.baysinger@uth.tmc.edu 
Phone: 713-500-6851
Principal Investigator: Maureen Mayes, MD, MPH
for more information - clinicaltrials.gov

SLEEP

 

Rapid Eye Movement Sleep Behavior Disorder & Parkinson's 
Coordinator Name: Vicki Ephron, RN 
E-mail: Vicki.J.Ephron@uth.tmc.edu 
Phone: 713-500-7073 
Principal Investigator: Mya C. Schiess, MD
for more information - clinicaltrials.gov

SUBSTANCE ABUSE

Cocaine Use Treatment Research Studies
Clinical Trial of Citalopram in Cocaine Dependence
Coordinator: Jessica Vincent
E-mail: Jessica.N.Vincent@uth.tmc.edu
Phone: 713-486-2803
Principal Investigator: Joy M. Schmitz, PhD
Cognitive-enhancing DA Medications for Cocaine Dependence
Coordinator: Jessica Vincent
E-mail: Jessica.N.Vincent@uth.tmc.edu
Phone: 713-486-2803
Principal Investigator: Joy M. Schmitz, PhD
PPAR Gamma Agonist Treatment for Cocaine Dependence
Coordinator: Jessica Vincent
E-mail: Jessica.N.Vincent@uth.tmc.edu
Phone: 713-486-2803
Principal Investigator: Ponnada Narayana, PhD

PTSD & Substance Use Treatment Study
Trial of a Novel Treatment for Posttraumatic Stress and Substance Dependence
Coordinator: Jessica Vincent
E-mail: Jessica.N.Vincent@uth.tmc.edu
Phone: 713-486-2803
Principal Investigator: Anka Vujanovic, PhD

Marijuana Study
Effects of Buspirone on Mood and Attention in Marijuana Users
Coordinator: Isabela Chapa
E-mail: Isabela.E.Chapa@uth.tmc.edu
Phone: 713-486-2794
Coordinator: Jessica Vincent
E-mail: Jessica.N.Vincent@uth.tmc.edu
Phone: 713-486-2803
Principal Investigator: Scott Lane, PhD

WEIGHT LOSS

Text Messaging for Weight Loss in Primary Care Patients
Coordinator Name: Landrus Burress
E-mail: Landrus.Burress@uth.tmc.edu
Phone: 713-500-7904
Principal Investigator: Kevin O. Hwang, MD
for more information - clinicaltrials.gov 

 

 

 

ADDITIONAL RESOURCES

CLINICAL RESEARCH UNITS (CRU) | BERD | REDCap
COMMITTEE FOR THE PROTECTION OF HUMAN SUBJECTS |ANIMAL RESEARCH | ENVIRONMENTAL HEALTH & SAFETY | CORE LABORATORIES | SPONSORED PROJECTS TECHNOLOGY MANAGEMENT
OFFICE OF RESEARCH 

Center for Clinical and Translational Sciences

Clinical Trials Resource Center (CTRC)
7000 Fannin Street, Suite 795

Houston, Texas 77030
phone 713-500-3622
fax 713-500-0334
clinicaltrials@uth.tmc.edu

last modified October, 2013
Copyright © 2012
How can we improve this site?